Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
New tool flags hidden sexual struggles in female partners of patients with prostate cancer
The partners of patients with prostate cancer grapple with their own quality-of-life issues that impact…
AI chatbots surpass clinicians in quality, empathy and readability in cancer patient responses
In a research letter by David Chen, Rod Parsa, Andrew Hope and colleagues, published in…
Caribbean teams innovate to protect cancer patients from compounding disasters
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine,…
New lung cancer biomarkers identified
- Immunotherapy plus chemotherapy combination for advanced lung cancer not only prolongs life but also improves its quality
- Pre-clinical study suggests that blocking a molecule while boosting a cell may reduce tumour growth in lung cancer patients
- ASTRO and ESTRO issue clinical guideline on local therapy for oligometastatic lung cancer
Climate change will give rise to more cancers
Climate change will bring an acute toll worldwide, with rising temperatures, bush fires and poor air quality, accompanied by higher…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.